Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03019861
Other study ID # AYURDA
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2017
Est. completion date February 2019

Study information

Verified date August 2021
Source Charite University, Berlin, Germany
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main goal of this randomized controlled clinical study is to evaluate the efficacy of an individual Ayurvedic nutritional counseling (according to tradition) compared to an individual conventional dietary advice (according to the German Nutrition Society - DGE) in patients with irritable bowel syndrome. It is to be investigated whether nutritional therapy elements, which patients can self-implement independently in the home environment, can achieve sustainable therapy effects.


Recruitment information / eligibility

Status Completed
Enrollment 69
Est. completion date February 2019
Est. primary completion date October 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Diagnosis "irritable bowel syndrome" according to the ROM-III criteria and the German S3 guideline (Layer 2011) - Female and male patients between 18 and 70 years of age - Declaration of consent Exclusion Criteria: - Bad general condition - Serious acute or chronic comorbidity - Pregnancy and breast feeding period - Eating disorder - In recognition procedures for early retirement or disability - Simultaneous participation in another clinical trial - Participation in a clinical trial within the last 3 months before enrollment

Study Design


Intervention

Behavioral:
Ayurvedic nutritional counseling

Conventional nutritional counseling


Locations

Country Name City State
Germany Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus Berlin
Germany Kliniken Essen-Mitte Essen Am Deimelsberg 34 A

Sponsors (1)

Lead Sponsor Collaborator
Charite University, Berlin, Germany

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Other Stool analysis: Intestinal microbiome by sequencing 16S rRNA Baseline, 4 weeks
Other Qualitative interviews in focus groups Baseline, 6 months
Primary Irritable Bowel Syndrome-Severity Scoring System (IBS-SSS) - Change Change from IBS-SSS Baseline at 12 weeks
Secondary Cohen Perceived Stress Scale (CPSS) - Change Change from CPSS Baseline at 4 weeks, 12 weeks and 6 months
Secondary Hospital Anxiety and Depression Scale (HADS-D) - Change Change from HADS-D Baseline at 4 weeks, 12 weeks and 6 months
Secondary Irritable bowel Syndrome - Quality of life (IBS-QOL) - Change Change from IBS-QOL Baseline at 4 weeks, 12 weeks and 6 months
Secondary VAS: Pain, Sleep, General bothersomeness, Expectation - Change Change from VAS Baseline at 4 weeks, 12 weeks and 6 months
Secondary Irritable Bowel Syndrome-Severity Scoring System (IBS-SSS) - Change Change from IBS-SSS Baseline at 4 weeks and 6 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05118243 - Innovative Tools to Produce Legume-based Foods for Increased Consumer Acceptance N/A
Completed NCT04422327 - The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome Phase 1/Phase 2
Recruiting NCT05178017 - Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS) N/A
Completed NCT05197413 - Study to Evaluate the Efficacy of Arrae's Bloat & Calm Alchemy Capsules to Reduce Bloating, Heartburn and Gas, and Alleviate the Intensity of IBS Symptoms N/A
Completed NCT04905524 - Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP) N/A
Recruiting NCT06297785 - Online, Gut-directed Hypnotherapy for Patients With Irritable Bowel Syndrome (IBS) N/A
Recruiting NCT05874830 - The Optimal Route of Fecal Microbiota Transplantation for Irritable Bowel Syndrome N/A
Active, not recruiting NCT04723056 - Zemedy Application for Irritable Bowel Syndrome N/A
Completed NCT05565612 - Clinical Trial to Evaluate the Effect of a Probiotic Mixture on Signs and Symptoms of Irritable Bowel Syndrome N/A
Recruiting NCT03131414 - The IMAGINE-SPOR CIHR Chronic Disease Network
Completed NCT03333291 - Fecal Transplantation in Patients With IBS N/A
Completed NCT03449628 - L. Casei DG® in Patients With Irritable Bowel Syndrome. N/A
Recruiting NCT06215222 - Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease
Completed NCT05016596 - Postprandial Lipids in IBS and Nutritional Treatment N/A
Recruiting NCT04760353 - The Effect of a Probiotic Mixture in Obese Patients With Irritable Bowel Syndrome N/A
Recruiting NCT04217733 - Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome Phase 3
Completed NCT03178877 - The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors N/A
Recruiting NCT05990764 - Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patients With Irritable Bowel Syndrome (IBS) N/A
Completed NCT03948854 - Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients N/A
Completed NCT04898257 - Effect of Lactibiane Tolerance® to Treat Leaky Gut in Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)Patients N/A